Co-organised by Parkway Shanghai Hospital, University of Hong Kong, Japan's Keio University, Shanghai First People's Hospital, and the Wu Mengchao Foundation the forum also marked the launch of the hospital’s International Hepatobiliary and Pancreatic Diagnosis and Treatment Centre.
In his welcome remarks, Dr Kenneth Tsang, Regional CEO of IHH Healthcare North Asia and CEO of Gleneagles Hospital Hong Kong, highlighted the growing complexity of hepatobiliary and pancreatic diseases and the need for closer collaboration. He shared how the IHH Healthcare North Asia network is strengthening knowledge exchange and accelerating the use of innovative treatments to improve patient outcomes.
Dr Tsang cited Histotripsy, a non-invasive liver cancer treatment introduced at Gleneagles Hospital Hong Kong in 2025, as an example of how innovation can change the way complex diseases are treated.
“By working together across our network, we can bring new solutions to patients faster and raise the standard of care across the region,” he said.
The newly launched Centre will serve as a multidisciplinary hub, bringing together expertise across surgery, gastroenterology, oncology and critical care. Supported by IHH Healthcare’s multinational network, it aims to deepen international collaboration, tackle complex cases and deliver more comprehensive care for patients across Asia.
Related Stories
Project Renaissance at Mount Elizabeth Hospital, Where Legacy Meets the Future of Care
Over a span of 1,095 days, Project Renaissance marked a significant chapter in the evolution of Mount Elizabeth Hospital, one of Singapore’s most established private healthcare institutions. Conceived as a strategic transformation rather than a conventional refurbishment, the initiative sought to position the hospital for the demands of a rapidly changing healthcare landscape.
IHH Healthcare North Asia Strengthens Integrated Care Through Strategic Partnership
2026 IHH Global Town Hall: Building a Future-ready Workforce
'Building a Future-ready Workforce' took centre stage at IHH Healthcare's 2026 Global Town Hall on 9 February, bringing colleagues together across 10 countries in a truly hybrid experience that underscored the group's commitment to future-proof healthcare.
IHH Malaysia Partners Libyan Government for Medical Referrals
IHH Healthcare Malaysia signed a Memorandum of Understanding (MOU) with The Government of Libya on 9 February, establishing a structured medical referral pathway for Libyan civil servants requiring specialist treatment at 18 hospitals across IHH’s Malaysian network.
Agilus Diagnostics Expands Access to Next-Generation Precision Genomics
Agilus Diagnostics, a subsidiary of Fortis Healthcare, has installed the Illumina NovaSeq X sequencing platform at its Mumbai reference laboratory, marking a major step forward for precision genomics in India.
